Tetracycline-class Drug [EPC]

Tetracycline-class Drug [EPC] was reported 70772 times

These side effects are most commonly reported by patients taking drugs of the Tetracycline-class Drug [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 5538
1 NAUSEA 5252
2 OFF LABEL USE 4978
3 FATIGUE 4939
4 RASH 4350
5 DIARRHOEA 4246
6 DYSPNOEA 4224
7 PAIN 4160
8 HEADACHE 4120
9 VOMITING 4013
10 DRUG HYPERSENSITIVITY 3861
11 MALAISE 3155
12 CONDITION AGGRAVATED 3109
13 PRURITUS 3079
14 DIZZINESS 3064
15 ARTHRALGIA 2941
16 PYREXIA 2836
17 PNEUMONIA 2804
18 CHRONIC KIDNEY DISEASE 2684
19 ANXIETY 2674
20 INFECTION 2456
21 ACUTE KIDNEY INJURY 2424
22 HYPERSENSITIVITY 2274
23 HYPERTENSION 2269
24 ABDOMINAL DISCOMFORT 2210
25 ASTHENIA 2199
26 SINUSITIS 2168
27 DECREASED APPETITE 2096
28 HYPOAESTHESIA 2040
29 JOINT SWELLING 1952
30 PRODUCT USE IN UNAPPROVED INDICATION 1939
31 INSOMNIA 1925
32 URTICARIA 1913
33 CHEST PAIN 1910
34 PAIN IN EXTREMITY 1863
35 RENAL FAILURE 1850
36 RHEUMATOID ARTHRITIS 1837
37 PERIPHERAL SWELLING 1821
38 ABDOMINAL PAIN UPPER 1812
39 WHEEZING 1807
40 WEIGHT DECREASED 1802
41 ABDOMINAL PAIN 1796
42 COUGH 1790
43 DEPRESSION 1790
44 NASOPHARYNGITIS 1784
45 ALOPECIA 1779
46 ASTHMA 1732
47 WEIGHT INCREASED 1725
48 CONFUSIONAL STATE 1695
49 DRUG INTOLERANCE 1690
50 INJURY 1636
51 SWELLING 1603
52 TREATMENT FAILURE 1583
53 GENERAL PHYSICAL HEALTH DETERIORATION 1582
54 HEPATIC ENZYME INCREASED 1579
55 DEATH 1543
56 INFUSION RELATED REACTION 1536
57 BLISTER 1520
58 MOBILITY DECREASED 1513
59 MUSCULOSKELETAL STIFFNESS 1459
60 WOUND 1405
61 GLOSSODYNIA 1396
62 CONTUSION 1393
63 GASTROINTESTINAL DISORDER 1386
64 FIBROMYALGIA 1371
65 SYSTEMIC LUPUS ERYTHEMATOSUS 1371
66 IMPAIRED HEALING 1365
67 TYPE 2 DIABETES MELLITUS 1362
68 SYNOVITIS 1344
69 STOMATITIS 1343
70 HELICOBACTER INFECTION 1332
71 MUSCLE SPASMS 1330
72 HAND DEFORMITY 1318
73 ANAEMIA 1314
74 ARTHROPATHY 1310
75 LOWER RESPIRATORY TRACT INFECTION 1300
76 PSORIATIC ARTHROPATHY 1300
77 GAIT DISTURBANCE 1289
78 DUODENAL ULCER PERFORATION 1277
79 FALL 1252
80 FOLLICULITIS 1243
81 BACK PAIN 1236
82 DRY MOUTH 1224
83 IRRITABLE BOWEL SYNDROME 1223
84 DISCOMFORT 1216
85 RHEUMATOID FACTOR POSITIVE 1216
86 INTENTIONAL PRODUCT USE ISSUE 1215
87 HAEMORRHAGE 1205
88 PRODUCT USE ISSUE 1198
89 OEDEMA PERIPHERAL 1195
90 OEDEMA 1189
91 PRODUCT DOSE OMISSION ISSUE 1185
92 BLOOD CHOLESTEROL INCREASED 1170
93 ERYTHEMA 1168
94 ROAD TRAFFIC ACCIDENT 1147
95 SLEEP DISORDER 1146
96 PARAESTHESIA 1144
97 RHEUMATIC FEVER 1134
98 DYSPEPSIA 1131
99 SCIATICA 1128
100 OSTEOARTHRITIS 1123
101 MATERNAL EXPOSURE DURING PREGNANCY 1119
102 GASTROOESOPHAGEAL REFLUX DISEASE 1109
103 PERICARDITIS 1083
104 LIVER INJURY 1059
105 MEMORY IMPAIRMENT 1050
106 PEMPHIGUS 1047
107 SWOLLEN JOINT COUNT INCREASED 1044
108 INFLAMMATION 1039
109 DRUG INTERACTION 1031
110 BRONCHITIS 1019
111 VISUAL IMPAIRMENT 1015
112 CONSTIPATION 996
113 LIVER DISORDER 991
114 CONTRAINDICATED PRODUCT ADMINISTERED 974
115 JOINT RANGE OF MOTION DECREASED 968
116 ILL-DEFINED DISORDER 967
117 MUSCULAR WEAKNESS 959
118 URINARY TRACT INFECTION 959
119 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 953
120 C-REACTIVE PROTEIN ABNORMAL 946
121 AUTOIMMUNE DISORDER 923
122 COVID-19 922
123 ARTHRITIS 920
124 LOWER LIMB FRACTURE 917
125 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 913
126 MUSCLE INJURY 911
127 DEEP VEIN THROMBOSIS POSTOPERATIVE 898
128 LUNG DISORDER 897
129 THROMBOCYTOPENIA 884
130 GAIT INABILITY 881
131 MIGRAINE 874
132 MYALGIA 870
133 HYPOTENSION 865
134 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 854
135 MUSCULOSKELETAL PAIN 838
136 ATRIAL FIBRILLATION 835
137 FEELING ABNORMAL 828
138 LIP DRY 822
139 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 819
140 THERAPEUTIC PRODUCT EFFECT DECREASED 811
141 THERAPY NON-RESPONDER 810
142 END STAGE RENAL DISEASE 807
143 AMNESIA 788
144 OSTEOPOROSIS 782
145 EMOTIONAL DISTRESS 758
146 PSORIASIS 753
147 UPPER RESPIRATORY TRACT INFECTION 752
148 FACET JOINT SYNDROME 745
149 NIGHT SWEATS 741
150 NEUTROPENIA 731
151 HYPERCHOLESTEROLAEMIA 725
152 TREMOR 710
153 PRESCRIBED OVERDOSE 702
154 WOUND INFECTION 698
155 PULMONARY FIBROSIS 697
156 C-REACTIVE PROTEIN INCREASED 683
157 ADVERSE DRUG REACTION 681
158 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 681
159 OROPHARYNGEAL PAIN 667
160 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 665
161 VISION BLURRED 663
162 SEPSIS 661
163 DEHYDRATION 655
164 BURSITIS 653
165 EAR INFECTION 653
166 CROHN^S DISEASE 652
167 CHILLS 650
168 DELIRIUM 650
169 CHEST DISCOMFORT 647
170 ILLNESS 637
171 SOMNOLENCE 632
172 NEUROPATHY PERIPHERAL 620
173 TACHYCARDIA 619
174 PRESCRIBED UNDERDOSE 618
175 OBESITY 615
176 DRY SKIN 614
177 GRIP STRENGTH DECREASED 578
178 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 577
179 BLOOD PRESSURE INCREASED 576
180 EYE PAIN 576
181 CELLULITIS 572
182 PRODUCTIVE COUGH 572
183 HEPATIC CIRRHOSIS 571
184 DRUG-INDUCED LIVER INJURY 567
185 DYSPHAGIA 566
186 PALPITATIONS 566
187 DISEASE PROGRESSION 563
188 PULMONARY EMBOLISM 562
189 RED BLOOD CELL SEDIMENTATION RATE INCREASED 562
190 INFLUENZA 556
191 JOINT STIFFNESS 555
192 ADVERSE EVENT 554
193 ABORTION INCOMPLETE 553
194 SKIN EXFOLIATION 549
195 SWELLING FACE 549
196 EXPOSURE DURING PREGNANCY 548
197 PREGNANCY 545
198 RASH PRURITIC 544
199 EXOSTOSIS 543
200 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 535
201 LUPUS VULGARIS 532
202 SYNCOPE 532
203 HOSPITALISATION 523
204 BONE EROSION 522
205 KNEE ARTHROPLASTY 517
206 INJECTION SITE PAIN 501
207 HIP ARTHROPLASTY 498
208 BREAST CANCER STAGE III 497
209 MEDICATION ERROR 497
210 SUICIDAL IDEATION 496
211 LOSS OF CONSCIOUSNESS 490
212 HYPERHIDROSIS 489
213 LARYNGITIS 489
214 DISLOCATION OF VERTEBRA 486
215 LUPUS-LIKE SYNDROME 482
216 JOINT DISLOCATION 477
217 PANCREATITIS 476
218 RENAL IMPAIRMENT 476
219 FOOT DEFORMITY 474
220 C-REACTIVE PROTEIN 470
221 ABDOMINAL DISTENSION 467
222 RENAL INJURY 453
223 PHOTOSENSITIVITY REACTION 452
224 FEBRILE NEUTROPENIA 451
225 NECK PAIN 442
226 COLITIS ULCERATIVE 440
227 LIVE BIRTH 440
228 RHINORRHOEA 440
229 ANHEDONIA 437
230 ACNE 435
231 HEART RATE INCREASED 432
232 DEEP VEIN THROMBOSIS 430
233 RETINITIS 428
234 TUBULOINTERSTITIAL NEPHRITIS 424
235 FEELING HOT 421
236 PERIPHERAL VENOUS DISEASE 418
237 EPISTAXIS 413
238 NEPHROGENIC ANAEMIA 409
239 RESPIRATORY FAILURE 409
240 TINNITUS 408
241 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 406
242 TOXICITY TO VARIOUS AGENTS 405
243 LIP SWELLING 400
244 HAEMOGLOBIN DECREASED 392
245 CARDIAC FAILURE CONGESTIVE 381
246 X-RAY ABNORMAL 380
247 RECTAL HAEMORRHAGE 379
248 BURNING SENSATION 376
249 HIDRADENITIS 375
250 BALANCE DISORDER 373
251 PLEURAL EFFUSION 372
252 STAPHYLOCOCCAL INFECTION 366
253 EAR PAIN 364
254 WHITE BLOOD CELL COUNT DECREASED 364
255 INCORRECT DOSE ADMINISTERED 362
256 DYSPNOEA EXERTIONAL 360
257 EYE IRRITATION 360
258 OVERDOSE 359
259 RESPIRATORY DISORDER 358
260 THROMBOSIS 351
261 WHITE BLOOD CELL COUNT INCREASED 349
262 FLUSHING 341
263 HALLUCINATION 341
264 THERAPEUTIC RESPONSE DECREASED 340
265 PLATELET COUNT DECREASED 337
266 PANCYTOPENIA 334
267 INTENTIONAL PRODUCT MISUSE 333
268 ANAPHYLACTIC REACTION 332
269 DRY EYE 331
270 DRUG RESISTANCE 329
271 MYOCARDIAL INFARCTION 326
272 RASH ERYTHEMATOUS 323
273 WALKING AID USER 322
274 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 322
275 STRESS 321
276 CYTOPENIA 320
277 HYPOKALAEMIA 318
278 SWOLLEN TONGUE 318
279 DEPRESSED MOOD 317
280 SKIN ULCER 317
281 UNDERDOSE 315
282 ALANINE AMINOTRANSFERASE INCREASED 314
283 JARISCH-HERXHEIMER REACTION 314
284 NASAL CONGESTION 314
285 OESOPHAGITIS 314
286 LIVER FUNCTION TEST INCREASED 312
287 ASPERGILLUS INFECTION 311
288 PANCREATITIS ACUTE 309
289 CEREBROVASCULAR ACCIDENT 304
290 DIABETES MELLITUS 302
291 LETHARGY 301
292 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 300
293 OXYGEN SATURATION DECREASED 299
294 SKIN LESION 299
295 BLOOD GLUCOSE INCREASED 298
296 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 296
297 NEPHROLITHIASIS 295
298 SEIZURE 295
299 ECONOMIC PROBLEM 294
300 EYE SWELLING 294
301 DYSPHONIA 291
302 ECZEMA 289
303 HOT FLUSH 289
304 NO ADVERSE EVENT 288
305 DISABILITY 287
306 GASTROINTESTINAL HAEMORRHAGE 286
307 HERPES ZOSTER 284
308 HYPOGLYCAEMIA 282
309 RESPIRATORY TRACT INFECTION 280
310 UNEVALUABLE EVENT 279
311 HYPONATRAEMIA 278
312 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 277
313 OCULAR HYPERAEMIA 272
314 FREQUENT BOWEL MOVEMENTS 270
315 DISEASE RECURRENCE 268
316 HAEMOPTYSIS 266
317 REBOUND ACID HYPERSECRETION 265
318 TREATMENT NONCOMPLIANCE 265
319 CATARACT 264
320 CARDIAC DISORDER 263
321 FLUID RETENTION 263
322 VERTIGO 263
323 MULTIPLE ORGAN DYSFUNCTION SYNDROME 259
324 SURGERY 259
325 DRUG TOLERANCE DECREASED 257
326 DYSURIA 257
327 BREATH SOUNDS ABNORMAL 256
328 CARDIAC FAILURE 255
329 RASH MACULAR 254
330 DRUG DOSE OMISSION 253
331 FUNGAL INFECTION 253
332 SKIN DISORDER 252
333 ASPARTATE AMINOTRANSFERASE INCREASED 251
334 BLOOD CREATININE INCREASED 250
335 LABORATORY TEST ABNORMAL 247
336 INFLUENZA LIKE ILLNESS 245
337 CARDIAC ARREST 243
338 HYPOXIA 243
339 LOCALISED INFECTION 243
340 STEVENS-JOHNSON SYNDROME 239
341 BONE PAIN 238
342 HAEMATOCHEZIA 237
343 SKIN BURNING SENSATION 237
344 HEPATITIS 234
345 TRANSIENT ISCHAEMIC ATTACK 233
346 SEPTIC SHOCK 232
347 DYSGEUSIA 231
348 DERMATITIS 229
349 BLOOD PRESSURE DECREASED 227
350 EPILEPSY 226
351 HYPERPARATHYROIDISM SECONDARY 226
352 LEUKOPENIA 226
353 PRODUCT QUALITY ISSUE 226
354 PHOTOPHOBIA 223
355 AGITATION 221
356 LYMPHADENOPATHY 218
357 MALIGNANT NEOPLASM PROGRESSION 217
358 CORONARY ARTERY DISEASE 216
359 SKIN DISCOLOURATION 213
360 GASTRITIS 210
361 RASH MACULO-PAPULAR 209
362 THERAPY INTERRUPTED 209
363 THROAT IRRITATION 208
364 TASTE DISORDER 206
365 INJECTION SITE ERYTHEMA 204
366 CLOSTRIDIUM DIFFICILE INFECTION 203
367 DISTURBANCE IN ATTENTION 203
368 INTERSTITIAL LUNG DISEASE 203
369 INTERNATIONAL NORMALISED RATIO INCREASED 201
370 POLLAKIURIA 201
371 SEASONAL ALLERGY 201
372 VIRAL INFECTION 200
373 BONE DENSITY DECREASED 199
374 JAUNDICE 199
375 PRODUCT DOSE OMISSION 199
376 FLATULENCE 198
377 PULMONARY OEDEMA 197
378 PANIC ATTACK 193
379 DRUG ERUPTION 192
380 JOINT INJURY 192
381 BRONCHIECTASIS 190
382 DERMATITIS ATOPIC 190
383 ANGIOEDEMA 189
384 OSTEOPENIA 189
385 CHOLELITHIASIS 188
386 ROSACEA 188
387 LIVER FUNCTION TEST ABNORMAL 187
388 OBSTRUCTIVE AIRWAYS DISORDER 187
389 DEAFNESS 185
390 ULCER 185
391 CANDIDA INFECTION 184
392 TOXIC EPIDERMAL NECROLYSIS 183
393 LACRIMATION INCREASED 182
394 ORAL CANDIDIASIS 182
395 ORAL PAIN 182
396 ACUTE RESPIRATORY FAILURE 181
397 DERMATITIS ACNEIFORM 181
398 DIVERTICULITIS 181
399 BASAL CELL CARCINOMA 180
400 OESOPHAGEAL ULCER 180
401 IRRITABILITY 179
402 PORPHYRIA ACUTE 179
403 RENAL DISORDER 179
404 LIMB DISCOMFORT 178
405 LYME DISEASE 178
406 OSTEOMYELITIS 177
407 SERONEGATIVE ARTHRITIS 177
408 FULL BLOOD COUNT ABNORMAL 176
409 HAEMATURIA 176
410 RIB FRACTURE 176
411 SCAR 176
412 SPEECH DISORDER 176
413 MATERNAL EXPOSURE TIMING UNSPECIFIED 175
414 BLOOD POTASSIUM DECREASED 174
415 MENORRHAGIA 174
416 SUICIDE ATTEMPT 174
417 ABORTION SPONTANEOUS 173
418 CYSTITIS 173
419 PAIN IN JAW 172
420 MICTURITION URGENCY 168
421 MOUTH ULCERATION 168
422 GASTRIC ULCER 166
423 SKIN INFECTION 166
424 TENDERNESS 166
425 LIMB INJURY 165
426 NERVOUSNESS 165
427 DEVICE ISSUE 164
428 EOSINOPHILIA 164
429 SLEEP APNOEA SYNDROME 163
430 ARRHYTHMIA 162
431 BREAST CANCER STAGE II 162
432 RENAL FAILURE ACUTE 162
433 HYPOACUSIS 161
434 WEIGHT FLUCTUATION 160
435 CHOLESTASIS 159
436 SINUS DISORDER 159
437 URINARY INCONTINENCE 159
438 CONJUNCTIVITIS 158
439 INJECTION SITE SWELLING 158
440 NIGHTMARE 158
441 PEMPHIGOID 157
442 THERAPEUTIC RESPONSE UNEXPECTED 157
443 COGNITIVE DISORDER 156
444 NAIL DISORDER 156
445 PNEUMONITIS 156
446 COMPLETED SUICIDE 155
447 PAIN OF SKIN 155
448 BENIGN PROSTATIC HYPERPLASIA 154
449 ULCER HAEMORRHAGE 153
450 COLITIS 152
451 HAEMATEMESIS 152
452 BRADYCARDIA 150
453 BLINDNESS 149
454 CARDIOMEGALY 149
455 DIPLOPIA 149
456 DRUG DEPENDENCE 149
457 FOETAL EXPOSURE DURING PREGNANCY 149
458 ELECTROCARDIOGRAM QT PROLONGED 148
459 EYE PRURITUS 148
460 PELVIC PAIN 148
461 RENAL TUBULAR NECROSIS 148
462 MENTAL STATUS CHANGES 147
463 SKIN FISSURES 147
464 SKIN IRRITATION 147
465 HYPERSOMNIA 146
466 LEUKOCYTOSIS 146
467 INTENTIONAL OVERDOSE 145
468 MUSCULOSKELETAL CHEST PAIN 145
469 THROAT TIGHTNESS 145
470 CYST 144
471 FIXED ERUPTION 144
472 ASCITES 143
473 ENCEPHALOPATHY 143
474 GRIP STRENGTH 143
475 THERAPY PARTIAL RESPONDER 143
476 HYPOMAGNESAEMIA 142
477 HYPOTHYROIDISM 142
478 INTERVERTEBRAL DISC PROTRUSION 142
479 INTRACRANIAL PRESSURE INCREASED 142
480 CHROMATURIA 141
481 INJECTION SITE BRUISING 141
482 DYSKINESIA 140
483 INFUSION SITE PAIN 140
484 MENTAL DISORDER 140
485 TENDONITIS 140
486 THERAPY CESSATION 140
487 VAGINAL HAEMORRHAGE 138
488 CRYING 137
489 DYSARTHRIA 136
490 FEAR 135
491 HYPERKALAEMIA 134
492 NEURALGIA 134
493 BLOOD ALKALINE PHOSPHATASE INCREASED 133
494 HIP FRACTURE 133
495 NODULE 133
496 BLEPHAROSPASM 132
497 HEAD INJURY 132
498 HYPOPHAGIA 132
499 PROTEINURIA 132
500 RASH GENERALISED 132
501 SPUTUM DISCOLOURED 132
502 PULMONARY MASS 131
503 RESTLESSNESS 131
504 ABDOMINAL PAIN LOWER 130
505 BODY TEMPERATURE INCREASED 130
506 PRODUCT DOSE OMISSION IN ERROR 130
507 SINUS CONGESTION 130
508 PRESYNCOPE 129
509 DISORIENTATION 128
510 INJECTION SITE PRURITUS 128
511 GASTRIC DISORDER 127
512 RASH PAPULAR 127
513 RED BLOOD CELL COUNT DECREASED 127
514 SNEEZING 127
515 CHOLANGITIS SCLEROSING 126
516 GASTROENTERITIS VIRAL 126
517 MOOD SWINGS 126
518 MUCOSAL INFLAMMATION 126
519 OVERLAP SYNDROME 126
520 PULMONARY HYPERTENSION 126
521 EYE DISORDER 124
522 HEART RATE DECREASED 124
523 BACTERIAL INFECTION 123
524 BONE DISORDER 123
525 OSTEONECROSIS OF JAW 123
526 RESPIRATORY DISTRESS 122
527 RHABDOMYOLYSIS 122
528 ABSCESS 121
529 CONVULSION 121
530 DERMATITIS CONTACT 121
531 FOOT FRACTURE 121
532 ONYCHOMADESIS 121
533 PALLOR 121
534 PLASMA CELL MYELOMA 121
535 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 120
536 HAEMATOMA 120
537 PRODUCT STORAGE ERROR 120
538 BACK DISORDER 119
539 FEELING COLD 119
540 HAEMORRHOIDS 119
541 AGEUSIA 118
542 CONGENITAL HIATUS HERNIA 118
543 GASTROINTESTINAL INJURY 118
544 KIDNEY INFECTION 118
545 RESPIRATORY TRACT CONGESTION 118
546 SUNBURN 118
547 UPPER GASTROINTESTINAL HAEMORRHAGE 118
548 THINKING ABNORMAL 117
549 DEVICE DISLOCATION 116
550 INTESTINAL OBSTRUCTION 116
551 HEAD DISCOMFORT 115
552 INJECTION SITE REACTION 115
553 ACCIDENTAL EXPOSURE TO PRODUCT 114
554 DYSSTASIA 114
555 HALLUCINATION, VISUAL 114
556 RESTLESS LEGS SYNDROME 114
557 URINARY RETENTION 114
558 CARDIO-RESPIRATORY ARREST 113
559 CLOSTRIDIUM DIFFICILE COLITIS 113
560 INTENTIONAL DOSE OMISSION 113
561 ARTHROPOD BITE 112
562 DRUG ABUSE 112
563 MOVEMENT DISORDER 112
564 SWOLLEN JOINT COUNT 112
565 ACUTE RESPIRATORY DISTRESS SYNDROME 111
566 ATELECTASIS 111
567 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 111
568 PSYCHOTIC DISORDER 111
569 QUALITY OF LIFE DECREASED 111
570 BRAIN FOG 110
571 FAECES DISCOLOURED 110
572 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 110
573 MUSCULOSKELETAL DISCOMFORT 110
574 RETCHING 110
575 SPONDYLITIS 110
576 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 109
577 HYPERTRANSAMINASAEMIA 109
578 TRANSAMINASES INCREASED 109
579 CARDIOMYOPATHY 108
580 ORAL HERPES 108
581 TOOTHACHE 108
582 BLOOD PRESSURE FLUCTUATION 107
583 BLOOD SODIUM DECREASED 107
584 CARPAL TUNNEL SYNDROME 107
585 HEART RATE IRREGULAR 107
586 HYPERGLYCAEMIA 107
587 INSURANCE ISSUE 107
588 SKIN REACTION 107
589 TOOTH INFECTION 107
590 TOOTH LOSS 107
591 HYPERCALCAEMIA 106
592 HEPATIC CYTOLYSIS 105
593 IMMUNODEFICIENCY 105
594 PATHOGEN RESISTANCE 105
595 METABOLIC ACIDOSIS 104
596 NEPHROPATHY 104
597 POOR QUALITY SLEEP 104
598 PRODUCT PRESCRIBING ISSUE 104
599 SHOCK 104
600 DRUG TOLERANCE 103
601 GALLBLADDER DISORDER 103
602 NEUTROPHIL COUNT DECREASED 103
603 OSTEONECROSIS 103
604 PROCEDURAL PAIN 103
605 VASCULITIS 103
606 EYE INFECTION 102
607 HAEMATOCRIT DECREASED 102
608 ODYNOPHAGIA 102
609 SPINAL OSTEOARTHRITIS 102
610 HEPATOTOXICITY 101
611 PERICARDIAL EFFUSION 101
612 GOUT 100
613 HEPATIC FAILURE 100
614 HEPATIC STEATOSIS 100
615 SPINAL FUSION SURGERY 100
616 UTERINE PERFORATION 100
617 HYPERLIPIDAEMIA 99
618 LACTIC ACIDOSIS 99
619 PRODUCT SUBSTITUTION ISSUE 99
620 AGGRESSION 98
621 BACK INJURY 98
622 PAPULE 98
623 TENDON PAIN 98
624 TOOTH DISORDER 98
625 INFUSION SITE ERYTHEMA 97
626 INTERVERTEBRAL DISC DEGENERATION 97
627 MULTIPLE ALLERGIES 97
628 MYOSITIS 97
629 NEOPLASM MALIGNANT 97
630 BLOOD PRESSURE SYSTOLIC INCREASED 96
631 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 96
632 MASS 96
633 PRODUCT ADMINISTRATION INTERRUPTED 96
634 SKIN CANCER 96
635 CHOLECYSTITIS CHRONIC 95
636 FACIAL PAIN 95
637 MUSCLE TWITCHING 95
638 THERAPEUTIC RESPONSE SHORTENED 95
639 TOOTH ABSCESS 95
640 DERMATITIS BULLOUS 94
641 FEELING JITTERY 94
642 PRODUCT ADMINISTRATION ERROR 94
643 AGRANULOCYTOSIS 93
644 PARAESTHESIA ORAL 93
645 PHARYNGEAL OEDEMA 93
646 SCAB 93
647 VENTRICULAR TACHYCARDIA 93
648 AUTOIMMUNE HEPATITIS 92
649 EATING DISORDER 92
650 FURUNCLE 92
651 MELAENA 92
652 MENTAL IMPAIRMENT 92
653 MOOD ALTERED 92
654 PSEUDOMONAS INFECTION 92
655 BLOOD COUNT ABNORMAL 91
656 DENTAL CARIES 91
657 EMOTIONAL DISORDER 91
658 MOUTH SWELLING 91
659 ORTHOSTATIC HYPOTENSION 91
660 RASH PUSTULAR 91
661 ANGINA PECTORIS 90
662 BLOOD BILIRUBIN INCREASED 90
663 ERECTILE DYSFUNCTION 90
664 PHARYNGITIS 90
665 VITAMIN D DEFICIENCY 90
666 ADRENAL INSUFFICIENCY 89
667 INFUSION SITE SWELLING 89
668 RENAL CYST 89
669 SKIN HAEMORRHAGE 89
670 FULL BLOOD COUNT DECREASED 88
671 OCULAR DISCOMFORT 88
672 PNEUMOTHORAX 88
673 SKIN HYPERPIGMENTATION 88
674 APHASIA 87
675 DRUG WITHDRAWAL SYNDROME 87
676 MALIGNANT MELANOMA IN SITU 87
677 PARONYCHIA 87
678 PNEUMONIA ASPIRATION 87
679 REBOUND EFFECT 87
680 UPPER LIMB FRACTURE 87
681 DERMATITIS ALLERGIC 86
682 PULMONARY PAIN 86
683 SKIN PLAQUE 86
684 SPINAL FRACTURE 86
685 ACUTE HEPATIC FAILURE 85
686 ANKLE FRACTURE 85
687 COAGULOPATHY 85
688 INJECTION SITE HAEMORRHAGE 85
689 MULTIPLE SCLEROSIS 85
690 BRONCHOSPASM 84
691 DEVICE BREAKAGE 84
692 DEVICE MALFUNCTION 84
693 HIATUS HERNIA 84
694 PARANOIA 84
695 BACTERAEMIA 83
696 EYE DISCHARGE 83
697 IMPAIRED GASTRIC EMPTYING 83
698 MULTIPLE FRACTURES 83
699 POST PROCEDURAL COMPLICATION 83
700 BLOOD URINE PRESENT 82
701 COVID-19 PNEUMONIA 82
702 FEMUR FRACTURE 82
703 IMPAIRED QUALITY OF LIFE 82
704 SMALL INTESTINAL OBSTRUCTION 82
705 SUBCUTANEOUS ABSCESS 82
706 UPPER-AIRWAY COUGH SYNDROME 82
707 ACUTE MYOCARDIAL INFARCTION 81
708 HYPOCALCAEMIA 81
709 PERIPHERAL COLDNESS 81
710 PNEUMONIA BACTERIAL 81
711 BLOOD MAGNESIUM DECREASED 80
712 BONE MARROW FAILURE 80
713 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 80
714 MULTIPLE SCLEROSIS RELAPSE 80
715 PRE-EXISTING CONDITION IMPROVED 80
716 PULMONARY THROMBOSIS 80
717 UNRESPONSIVE TO STIMULI 80
718 ACTIVITIES OF DAILY LIVING IMPAIRED 79
719 BLOOD PRESSURE ABNORMAL 79
720 CYSTIC FIBROSIS 79
721 HEPATIC FUNCTION ABNORMAL 79
722 IMPAIRED WORK ABILITY 79
723 PANNICULITIS 79
724 PHARYNGEAL SWELLING 79
725 POST PROCEDURAL INFECTION 79
726 RHEUMATOID NODULE 79
727 ROTATOR CUFF SYNDROME 79
728 SKIN NECROSIS 79
729 ABNORMAL BEHAVIOUR 78
730 ACCIDENTAL OVERDOSE 78
731 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 78
732 DEVICE RELATED INFECTION 78
733 INFLAMMATORY BOWEL DISEASE 78
734 VISUAL ACUITY REDUCED 78
735 ABNORMAL DREAMS 77
736 BLOOD CREATINE PHOSPHOKINASE INCREASED 77
737 MIDDLE INSOMNIA 77
738 PRURITUS GENERALISED 77
739 RASH VESICULAR 77
740 ABSCESS LIMB 76
741 ARTERIOSCLEROSIS 76
742 BLOOD IRON DECREASED 76
743 NOCTURIA 76
744 PAPILLOEDEMA 76
745 POLYARTHRITIS 76
746 COELIAC DISEASE 75
747 COLD SWEAT 75
748 DIARRHOEA HAEMORRHAGIC 75
749 FOREIGN BODY SENSATION IN EYES 75
750 GLAUCOMA 75
751 LYMPHOEDEMA 75
752 MYOCARDIAL ISCHAEMIA 75
753 NORMAL NEWBORN 75
754 SKIN MASS 75
755 SPLENOMEGALY 75
756 ARTHRITIS INFECTIVE 74
757 METHAEMOGLOBINAEMIA 74
758 PULMONARY CONGESTION 74
759 SKIN LACERATION 74
760 SUPRAVENTRICULAR TACHYCARDIA 74
761 VITREOUS FLOATERS 74
762 WITHDRAWAL SYNDROME 74
763 ORAL DISCOMFORT 73
764 RENAL PAIN 73
765 SEROTONIN SYNDROME 73
766 TARDIVE DYSKINESIA 73
767 APHONIA 72
768 HEPATIC ENCEPHALOPATHY 72
769 LIGAMENT SPRAIN 72
770 LYMPHOCYTE COUNT DECREASED 72
771 MUSCLE SPASTICITY 72
772 MUSCLE STRAIN 72
773 ORAL MUCOSAL BLISTERING 72
774 PELVIC INFLAMMATORY DISEASE 72
775 RALES 72
776 TENDON RUPTURE 72
777 BLOOD GLUCOSE DECREASED 71
778 EAR DISCOMFORT 71
779 GRANULOMA SKIN 71
780 INFLAMMATORY MARKER INCREASED 71
781 MALNUTRITION 71
782 MITRAL VALVE INCOMPETENCE 71
783 NERVOUS SYSTEM DISORDER 71
784 SJOGREN^S SYNDROME 71
785 SUSPECTED OFF LABEL USE 71
786 BLOOD PARATHYROID HORMONE DECREASED 70
787 FLANK PAIN 70
788 INFUSION SITE REACTION 70
789 PHARYNGITIS STREPTOCOCCAL 70
790 TOOTH FRACTURE 70
791 CONGENITAL ANOMALY 69
792 DRUG EFFECT DECREASED 69
793 FEEDING DISORDER 69
794 FISTULA 69
795 HERNIA 69
796 HYPERAESTHESIA 69
797 BLOOD UREA INCREASED 68
798 CHOLESTATIC LIVER INJURY 68
799 CIRCULATORY COLLAPSE 68
800 LUNG NEOPLASM MALIGNANT 68
801 SQUAMOUS CELL CARCINOMA 68
802 BLOOD TRIGLYCERIDES INCREASED 67
803 INCREASED TENDENCY TO BRUISE 67
804 LUNG INFECTION 67
805 PNEUMOCYSTIS JIROVECII PNEUMONIA 67
806 SECRETION DISCHARGE 67
807 SWELLING OF EYELID 67
808 WRIST FRACTURE 67
809 ELECTROLYTE IMBALANCE 66
810 GROIN PAIN 66
811 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 66
812 MAJOR DEPRESSION 66
813 OESOPHAGEAL PAIN 66
814 PERIORBITAL SWELLING 66
815 SINUS TACHYCARDIA 66
816 ANOSMIA 65
817 DRY THROAT 65
818 GLOMERULAR FILTRATION RATE DECREASED 65
819 HYPOAESTHESIA ORAL 65
820 IMMUNE SYSTEM DISORDER 65
821 IRON DEFICIENCY ANAEMIA 65
822 ISCHAEMIC CARDIOMYOPATHY 65
823 APPETITE DISORDER 64
824 CARDIOVASCULAR DISORDER 64
825 DECREASED ACTIVITY 64
826 DRUG LEVEL INCREASED 64
827 EMPHYSEMA 64
828 EYE INJURY 64
829 HAIR COLOUR CHANGES 64
830 LUNG INFILTRATION 64
831 NEOPLASM PROGRESSION 64
832 SPINAL PAIN 64
833 THIRST 64
834 GASTRITIS EROSIVE 63
835 HYPERTHYROIDISM 63
836 HYPERVOLAEMIA 63
837 LUNG CONSOLIDATION 63
838 NEEDLE ISSUE 63
839 PETECHIAE 63
840 SENSORY DISTURBANCE 63
841 TACHYPNOEA 63
842 EYE INFLAMMATION 62
843 FACE OEDEMA 62
844 FLUID OVERLOAD 62
845 GASTROINTESTINAL INFECTION 62
846 MUSCLE TIGHTNESS 62
847 AMYLOID ARTHROPATHY 61
848 ANGER 61
849 ASPIRATION 61
850 BONE LOSS 61
851 IDIOPATHIC INTRACRANIAL HYPERTENSION 61
852 INCONTINENCE 61
853 LOCAL SWELLING 61
854 MUSCULOSKELETAL DISORDER 61
855 NEUTROPENIC SEPSIS 61
856 ONYCHOMYCOSIS 61
857 PURPURA 61
858 SKIN WARM 61
859 TEMPERATURE INTOLERANCE 61
860 HERPES SIMPLEX 60
861 HORDEOLUM 60
862 INJECTION SITE MASS 60
863 LYMPHOPENIA 60
864 RHINITIS 60
865 TENDON DISORDER 60
866 BREAST CANCER 59
867 MELANOCYTIC NAEVUS 59
868 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 59
869 PRODUCT USE COMPLAINT 59
870 PUSTULE 59
871 DIVERTICULUM 58
872 ECCHYMOSIS 58
873 EJECTION FRACTION DECREASED 58
874 FRACTURE 58
875 INFUSION SITE PRURITUS 58
876 JOINT EFFUSION 58
877 NEUROTOXICITY 58
878 BLOOD CALCIUM DECREASED 57
879 CEREBRAL INFARCTION 57
880 EXPOSURE VIA SKIN CONTACT 57
881 HAEMOLYTIC ANAEMIA 57
882 HALLUCINATION, AUDITORY 57
883 HICCUPS 57
884 NERVE INJURY 57
885 OVARIAN CYST 57
886 PANIC REACTION 57
887 PUSTULAR PSORIASIS 57
888 SARS-COV-2 TEST POSITIVE 57
889 AORTIC ANEURYSM 56
890 BLOOD POTASSIUM INCREASED 56
891 ERUCTATION 56
892 GAMMA-GLUTAMYLTRANSFERASE INCREASED 56
893 INCREASED APPETITE 56
894 INITIAL INSOMNIA 56
895 ONYCHOCLASIS 56
896 SEDATION 56
897 SPINAL COMPRESSION FRACTURE 56
898 THYROID DISORDER 56
899 CARDIAC MURMUR 55
900 CHOKING 55
901 CHRONIC SINUSITIS 55
902 DEPRESSED LEVEL OF CONSCIOUSNESS 55
903 ENDOMETRITIS 55
904 GASTROINTESTINAL MUCOSAL NECROSIS 55
905 GENERALISED OEDEMA 55
906 GINGIVAL BLEEDING 55
907 GINGIVAL PAIN 55
908 HEPATOCELLULAR INJURY 55
909 HYPERBILIRUBINAEMIA 55
910 INFUSION SITE DISCHARGE 55
911 PARANASAL SINUS DISCOMFORT 55
912 PULMONARY FUNCTION TEST ABNORMAL 55
913 SPINAL DISORDER 55
914 VAGINAL INFECTION 55
915 CHEILITIS 54
916 ESCHERICHIA INFECTION 54
917 FOOD ALLERGY 54
918 HEPATOMEGALY 54
919 HOSPICE CARE 54
920 INCORRECT PRODUCT ADMINISTRATION DURATION 54
921 MUSCLE ATROPHY 54
922 PARKINSON^S DISEASE 54
923 POLYNEUROPATHY 54
924 PRODUCT AVAILABILITY ISSUE 54
925 RESPIRATORY ARREST 54
926 TACHYARRHYTHMIA 54
927 WOUND SECRETION 54
928 APHTHOUS ULCER 53
929 EOSINOPHIL COUNT INCREASED 53
930 GASTROENTERITIS 53
931 METASTASES TO LIVER 53
932 MULTI-ORGAN FAILURE 53
933 PLATELET COUNT INCREASED 53
934 ANAPHYLACTIC SHOCK 52
935 DEFORMITY 52
936 DEMENTIA 52
937 DIZZINESS POSTURAL 52
938 HAIR TEXTURE ABNORMAL 52
939 INFUSION SITE EXTRAVASATION 52
940 MENSTRUATION IRREGULAR 52
941 NEUTROPHIL COUNT INCREASED 52
942 SKIN ABRASION 52
943 BRONCHIAL HYPERREACTIVITY 51
944 CHOLECYSTITIS 51
945 DEVICE DIFFICULT TO USE 51
946 DISSEMINATED INTRAVASCULAR COAGULATION 51
947 DRUG ADMINISTRATION ERROR 51
948 DYSTONIA 51
949 EYELID OEDEMA 51
950 GLYCOSYLATED HAEMOGLOBIN INCREASED 51
951 INFUSION SITE HAEMORRHAGE 51
952 POST-TRAUMATIC STRESS DISORDER 51
953 RHINITIS ALLERGIC 51
954 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 51
955 VASCULAR DEVICE INFECTION 51
956 APPLICATION SITE ERYTHEMA 50
957 COMA 50
958 DIABETES MELLITUS INADEQUATE CONTROL 50
959 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 50
960 IMMUNOSUPPRESSION 50
961 INJECTION SITE URTICARIA 50
962 LEFT VENTRICULAR DYSFUNCTION 50
963 LIPASE INCREASED 50
964 NEPHROPATHY TOXIC 50
965 PERIPHERAL VASCULAR DISORDER 50
966 POOR VENOUS ACCESS 50
967 POSTOPERATIVE WOUND INFECTION 50
968 SUBDURAL HAEMATOMA 50
969 BLOOD ALBUMIN DECREASED 49
970 CEREBRAL HAEMORRHAGE 49
971 DUODENAL ULCER 49
972 EXTRA DOSE ADMINISTERED 49
973 GENITAL HAEMORRHAGE 49
974 HALLUCINATIONS, MIXED 49
975 INTERNAL HAEMORRHAGE 49
976 NERVE COMPRESSION 49
977 OBSESSIVE-COMPULSIVE DISORDER 49
978 SINUS BRADYCARDIA 49
979 SINUS HEADACHE 49
980 SPINAL OPERATION 49
981 SQUAMOUS CELL CARCINOMA OF SKIN 49
982 ULCERATIVE KERATITIS 49
983 ARTERIOSCLEROSIS CORONARY ARTERY 48
984 BLOOD PRESSURE DIASTOLIC DECREASED 48
985 CUSHINGOID 48
986 DECUBITUS ULCER 48
987 GASTROINTESTINAL PAIN 48
988 HAND FRACTURE 48
989 IMPAIRED DRIVING ABILITY 48
990 INJECTION SITE RASH 48
991 LOCALISED OEDEMA 48
992 MULTIPLE INJURIES 48
993 PAROSMIA 48
994 PRODUCT DISTRIBUTION ISSUE 48
995 PULMONARY TOXICITY 48
996 RAYNAUD^S PHENOMENON 48
997 RESPIRATION ABNORMAL 48
998 RESPIRATORY SYNCYTIAL VIRUS INFECTION 48
999 SKIN SWELLING 48